BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6530765)

  • 1. [Therapy of systemic lupus erythematosus--studies using disease models. 3. Effect of cyclosporin A on spontaneous autoimmune diseases].
    Okuhira K; Hayakawa H; Yoshisawa H; Okuhira H; Terada E
    Nihon Rinsho; 1984 Dec; 42(12):2800-6. PubMed ID: 6530765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of interstitial pneumonia in autoimmune mice with cyclosporin A].
    Okudaira H; Ogita T; Miyamoto T; Shiga J; Suko M; Okudaira K; Terada E; Ghoda A; Terada K; Saito M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Oct; 22(10):880-4. PubMed ID: 6530853
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies.
    Gunn HC
    Clin Exp Immunol; 1986 May; 64(2):225-33. PubMed ID: 3488856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental autoimmunity.
    Nussenblatt RB; Gunn HC; Ryffel B; Borel JF
    Prog Allergy; 1986; 38():159-80. PubMed ID: 3487790
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine in autoimmune diseases.
    Bach JF
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):97-113. PubMed ID: 2741212
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The combination of cyclosporin A and fluocortolone in the treatment of autoimmune diseases].
    Aresu G; Pascalis L; Pia G
    Clin Ter; 1989 Oct; 131(1):3-21. PubMed ID: 2531058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NZB/W mice: an animal model of systemic lupus erythematosus].
    GliƄski W
    Przegl Dermatol; 1976; 63(2):217-23. PubMed ID: 1083547
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lupus diseases].
    Gilbert D; Margaritte C; Brard F; Tron F
    Rev Prat; 1994 Jan; 44(1):57-61. PubMed ID: 8178060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
    Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
    J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus.
    Goust JM
    Immunol Ser; 1990; 50():449-63. PubMed ID: 2151125
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of cyclosporine A in the treatment of connective tissue diseases.
    Miescher PA; Favre H; Mihatsch MJ; Chatelanat F; Huang YP; Zubler R
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):224-37. PubMed ID: 3381275
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental use of murine lupus models.
    Peng SL
    Methods Mol Med; 2004; 102():227-72. PubMed ID: 15286389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis in NZB/W mice: therapeutic effect of cyclosporine.
    Gunn HC; Ryffel B
    Clin Nephrol; 1986; 25 Suppl 1():S189-92. PubMed ID: 3708931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciclosporin treatment in experimental autoimmune myasthenia gravis.
    Gunn HC; Hiestand PC; Hanglow AC
    Monogr Allergy; 1988; 25():96-107. PubMed ID: 3262820
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic strategies in autoimmune disease: cyclosporin A as a model agent.
    Lemley DE; Katz P
    In Vivo; 1988; 2(1):115-8. PubMed ID: 2979810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
    Appleby P; Webber DG; Bowen JG
    Clin Exp Immunol; 1989 Dec; 78(3):449-53. PubMed ID: 2612055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine as a new approach to therapy of autoimmune diseases.
    Borel JF; Gunn HC
    Ann N Y Acad Sci; 1986; 475():307-19. PubMed ID: 3538973
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim report of clinical studies presented at the International Symposium on Ciclosporin in Auto-Immune Diseases, Basel, March 18-20, 1985.
    Schmitz-Schumann M
    Prog Allergy; 1986; 38():436-46. PubMed ID: 3755240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.